Lawsuit Filed on Behalf of San Francisco City and County Against Prescription Opioid Manufacturers

San Francisco Opioid Lawsuit Filed

The City Attorney of San Francisco, Dennis Herrera, in conjunction with Lieff Cabraser and co-counsel, has filed a federal class action lawsuit on behalf of the City and County of San Francisco against the major pharmaceutical companies and distributors responsible for the manufacturing, transmission, and sale of dangerous, highly addictive and often lethal prescription opioids such as Oxycontin and fentanyl in San Francisco. The lawsuit alleges these companies orchestrated a widespread fraud in which they made billions by deceptively marketing these drugs to the people of San Francisco while representing the drugs as safe and effective, creating thousands upon thousands of addicts. [Read more…]

Lieff Cabraser Announces Filing of Lawsuit by Cannon County, Tennessee Against Prescription Opioid Manufacturers

Opioids Lawsuit Filed

Lawsuit Seeks Recovery of Taxpayer Monies Spent Combating the Opioid Epidemic Wreaking Havoc on the Cannon County Community; Cannon Joins Other Tennessee Cities and Counties Fighting For Justice After Opiate Drug Devastation

SAN FRANCISCO—(BUSINESS WIRE)—Mark Chalos, of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that Cannon County, Tennessee has filed a lawsuit against prescription opioid manufacturers and distributors to recover taxpayer money spent to combat the opioid epidemic that is devastating the Cannon County community. This case arises out of the worst man-made epidemic in modern medical history—the misuse, abuse, and over-prescription of opioid prescription drugs. [Read more…]

Mark Chalos Talks to NPR About Nashville’s Lawsuit Against the Opioid Industry

Mark Chalos Talks to NPR About Nashville’s Lawsuit Against the Opioid Industry

On April 30, 2018, Lieff Cabraser partner Mark P. Chalos spoke to National Public Radio (NPR) about the lawsuit filed by the City of Nashville, TN against the pharmaceutical industry in the wake of the opioid drug epidemic plaguing the Nashville area as well as the rest of Tennessee and the wider United States. [Read more…]

Lieff Cabraser and Co-Counsel to Represent Broward County & the City of Fort Lauderdale in Opioid Litigation

Lieff Cabraser Opioid Lawsuits

Broward County and the city of Fort Lauderdale have announced that they will be represented by a team of five law firms, including Lieff Cabraser Heimann & Bernstein, in litigation against pharmaceutical companies and drug distributors for their alleged roles in the devastating and ongoing opioid crisis. The other firms on the team are Haliczer Pettis & Schwamm, Kopelowitz Ostrow Ferguson Weiselberg Gilbert, Morgan & Morgan, and Robbins Geller Rudman & Dowd. [Read more…]

Mark Chalos Talks to Governing About America’s Lethal Opioid Crisis

Mark Chalos Talks to Governing About America's Lethal Opioid Crisis

Over 100 States and Cities Are Now Suing Drug Companies Over Pandemic Opioid Deaths and Addictions Nationwide

Governing has published a new report on the wide proliferation of lawsuits filed by cities and states against prescription drugmakers for their role in the nation’s opioid epidemic. As the platform notes, new opioid harm lawsuits are being filed almost every week. Unlike most drug epidemics, the opioid scourge is driven largely by a legal industry — the prescription drug system. The National Institute on Drug Abuse estimates that 75 percent of people who enter treatment for a heroin addiction took their first opioid legally from a prescription. [Read more…]

$300 Million Settlement in Benicar Litigation Over Drug Injury Claims

$300 Million Settlement in Benicar Litigation Over Drug Injury Claims

A $300 million settlement has been reached in the multidistrict Benicar litigation against Daiichi Sankyo Inc. and Forest Laboratories Inc. on claims that the top-selling blood pressure drug caused severe, and sometimes life-threatening, gastrointestinal injuries in users. [Read more…]

Bristol-Myers Squibb Pays $19.5 Million Over Improper Abilify Drug Marketing

Abilify Gambling Addiction Injuries

Bristol-Myers Squibb has agreed to pay $19.5 million to settle claims of improper advertising relating to its top-selling drug Abilify. 42 states and Washington D.C. alleged that the company improperly advertised antipsychotic drug Abilify, first approved in 2002 by the FDA to treat schizophrenic in adults. However, Bristol-Myers Squibb thereafter began promoting Abilify for off-label uses not approved by the FDA. These off-label uses had not been established as safe or effective. [Read more…]

Abilify Gambling Lawsuits Consolidated in Florida Federal Court

Abilify Gambling Lawsuits Consolidated in Florida Federal Court

The Judicial Panel on Multidistrict Litigation has consolidated more than 20 lawsuits against Bristol-Myers Squibb Co. over claims of pathological gambling side effects in patients using the antipsychotic drug Abilify in federal court in Florida. The serious impulse-control problems described in the complaints reportedly stop when the medicine is discontinued. 22 actions pending in 12 districts will be centralized under Chief District Judge M. Casey Rodgers. [Read more…]